期刊文献+

援助利比里亚埃博拉诊疗中心的药品保障与药师工作模式探讨 被引量:1

原文传递
导出
摘要 目的探讨中国援助利比里亚埃博拉诊疗中心药品保障与药师工作的模式,为类似医疗援助及特殊地区传染病医院中药师工作模式与方法提供参考。方法通过总结援助利比里亚埃博拉诊疗中心的药师工作经历,就此次医疗救助中药品的准备、保障及药师在临床诊疗中发挥的重要作用进行探讨。结果在埃博拉诊疗中心特殊的药品保障和工作模式下,药师的工作及开展的药学服务为临床诊疗发挥了重要作用。结论医院药师可因地制宜地在类似医疗救助中发挥更为重要的作用。
出处 《中国临床药学杂志》 CAS 2016年第1期54-57,共4页 Chinese Journal of Clinical Pharmacy
  • 相关文献

参考文献10

  • 1Word Health Orgnization(WHO):Ebola situation report[EB/OL][2015-05-13].http://apps.who.int/ebola/en/ebola-situation-reports. 被引量:1
  • 2Chiapperlli F,Bakhordarian A,Thames AD,et al.Ebola:translational science considerations[J].J Tranl Med,2015,13(1):11. 被引量:1
  • 3Lee BY,Moss WJ,Privor-Dumm L,et al.Is the world ready for an Ebola vaccine?[J].Lancet,2015,385(1):203. 被引量:1
  • 4Iroezindu MO,Unigwe US,Okwara CC,et al.Lessons leamt from the management of a case of Lassa fever and follow-up of nosocomial primary contacts in Nigeria during Ebola virus disease outbreak in West Africa[J].Trap Med Int Health.2015 Jul 14.doi:10.1111/tmi.12565. 被引量:1
  • 5Hensley LE,Dyall J,Olinger GG Jr,et al.Lack of effect of lamivudine on Ebola virus replication[J].Emerg Infect Dis,2015,21(3):550. 被引量:1
  • 6Kupferschmidt K,Cohen J.Infectious diseases.Ebola drug trials lurch ahead[J].Science,2015,13,347(6223):701. 被引量:1
  • 7Wozzniak-Kose kA,Kosek J,Mierzejewski J,et al.Progress in the diagnosis and control of Ebola disease[J].Adv Exp Med Biol,2015,857:19. 被引量:1
  • 8WHO.Ebola Response Team,Agua-Agum J,Ariyarajah A,et al.Ebola virus disease among children in West Africa[J].N Engl J Med,2015,372(13):1274. 被引量:1
  • 9Kendall RE,Gosser RA,Schulz LT,et al.Anti-diarrheal medication use in the treatment of Ebola virus-induced diarrhea[J].Travel Med Infect Dis,2015,13(2):205. 被引量:1
  • 10黄庆,张宏雁,毛青,枉前,游建平.埃博拉病毒病实验室检测方案的规划与实践[J].第三军医大学学报,2015,37(4):295-299. 被引量:6

二级参考文献7

  • 1World Health Organization (WHO). Laboratory guidance for the diagnosis of Ebola virus disease [ EB/OL] ( 2014-09-19 ) [ 2015-01-26 ]. http ://www. who. int/csr/resources! publications/ebola/laboratory-guidance/en/. 被引量:1
  • 2Centers for Disease Control and Prevention (CDC). Interim guidance for specimen coUection, transport, testing, and submission for persons under investigation (PUIs) for Ebola virus disease (EVD) in the United States [ EB/OL ] (2014- 10-20) [ 2015-01-26]. http://www, ede. gov/vhf/ebola/ healthcare-us/laboratories/specimens, html. 被引量:1
  • 3Centers for Disease Control and Prevention (CDC). How U. S. clinical laboratories can safely manage specimens from persons under investigation (PUIs) for Ebola virus disease (EVD) [ EB/OL ] (2014-11-10) [ 2015-01-26 ]. http:// www. cdc. gov/vhf/ebola/healthcare-us/laboratories/safe- specimen-management, html. 被引量:1
  • 4Huang Q, Yao C Y, Chen B, et al. Species-specific identification by inhibitor-controlled PCR of ruminant components contaminating industrial crude porcine heparin [J]. Mol Cell Probes, 2006, 20(3/4):250 -258. 被引量:1
  • 5Iwen P C, Smith P W, Hewlett A L, et al. Safety considerations in the laboratory testing of speeimens suspected or known to eontain ebola virus[ J]. Am J Clin Pathol, 2015, 143(1) :4 -5. 被引量:1
  • 6Hill C E, BuM E M, Kraft C S, et al. Laboratory test support for ebola patients within a high-containment facility [J]. Lab Med, 2014, 45 (3) : el09 - el 11. 被引量:1
  • 7Iwen P C, Garrett J L, Gibbs S G, et al. An integrated approach to laboratory testing for patients with ebola virus disease [J]. Lab Med, 2014, 45(4) :e146 -el51. 被引量:1

共引文献5

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部